Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies

Episode Description

Nature staff discuss how a newly approved orexin-targeting narcolepsy drug could enable therapies for other neurological conditions, and examine human brain organoids that have remained viable for more than five years. The episode connects sleep medicine, therapeutic neuroscience, and long-term models of human brain development.

Topics Discussed

More Episodes